Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

2025 Association for Public Policy Fall Research Conference (APPAM)

Join Abt Global at the 2025 Association for Public Policy Fall Research Conference (APPAM).

Learn More
Event

2025 American Criminology Association Annual Meeting (ASC)

Abt is proud to exhibit and present at the 2025 American Association of Criminology’s (ASC) Annual Meeting.

Learn More
Event

Advancing Military Family Health Through the Millennium Cohort Family Study

Abt Global is a key research partner to the Department Defense and Naval Health Research Center on the Millennium Cohort Family Study

Learn More
Project

Multi-site study of communities with PFAS-contaminated drinking water: Methods, demographics, and PFAS serum concentrations

Presents findings from a multi-site study examining the relationship between PFAS-contaminated drinking water and PFAS levels in residents’ blood across the U.S.

Learn More
Publication